GlakoLens
PrivateLast Round
Accelerator
Mar 21, 2025
Total Funding Raised
$1.38M
Company Overview
GlakoLens is a medtech company that develops a contact lens-based biosensor technology for intraocular pressure and glaucoma management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Health IoT, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlakoLens Comps
Public and private peers based on sector, stage, and business model.
GlakoLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 21, 2025 | ||||
| Grant | Oct 15, 2019 | ||||
| Grant | Sep 21, 2017 | ||||
| Seed | May 25, 2017 |
GlakoLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon 2020 | Grant |
| ETH Zurich | Grant |
| European Commission | Grant |
| Eurostars SME programme | Grant |
| Accelerace | Accelerator |
| CDP Venture Capital SGR | Accelerator |
| VITA Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 1733% MoM, from 3 to 55.
- Mar 21, 2025
$97K round led by VITA Accelerator
GlakoLens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlakoLens's valuation, stock price, and market status.
